Bank of New York Mellon Corp - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 273 filers reported holding CONMED CORP in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$43,226,731
-35.8%
428,624
-13.5%
0.01%
-28.6%
Q2 2023$67,326,644
+79.1%
495,449
+36.9%
0.01%
+75.0%
Q1 2023$37,587,500
+16.4%
361,906
-0.7%
0.01%
+14.3%
Q4 2022$32,298,650
+12.3%
364,380
+1.5%
0.01%0.0%
Q3 2022$28,771,000
-12.4%
358,872
+4.6%
0.01%
-12.5%
Q2 2022$32,842,000
-36.9%
342,957
-2.2%
0.01%
-20.0%
Q1 2022$52,084,000
+5.0%
350,626
+0.2%
0.01%
+11.1%
Q4 2021$49,623,000
+15.1%
350,051
+6.2%
0.01%
+12.5%
Q3 2021$43,124,000
-1.2%
329,620
+3.8%
0.01%0.0%
Q2 2021$43,662,000
+4.1%
317,705
-1.1%
0.01%
-11.1%
Q1 2021$41,947,000
+16.6%
321,228
-0.0%
0.01%
+12.5%
Q4 2020$35,980,000
+39.2%
321,238
-2.2%
0.01%
+33.3%
Q3 2020$25,846,000
+8.5%
328,544
-0.8%
0.01%0.0%
Q2 2020$23,832,000
+31.3%
331,048
+4.5%
0.01%0.0%
Q1 2020$18,145,000
-51.7%
316,792
-5.7%
0.01%
-40.0%
Q4 2019$37,585,000
-3.1%
336,083
-16.7%
0.01%
-9.1%
Q3 2019$38,807,000
+17.6%
403,594
+4.6%
0.01%
+22.2%
Q2 2019$33,009,000
-19.1%
385,762
-21.3%
0.01%
-18.2%
Q1 2019$40,789,000
+60.6%
490,371
+23.9%
0.01%
+37.5%
Q4 2018$25,399,000
-24.0%
395,642
-6.2%
0.01%
-11.1%
Q3 2018$33,422,000
+13.0%
421,887
+4.4%
0.01%
+12.5%
Q2 2018$29,574,000
+16.7%
404,036
+1.0%
0.01%
+14.3%
Q1 2018$25,336,000
+29.8%
400,072
+4.5%
0.01%
+40.0%
Q4 2017$19,523,000
-7.2%
383,017
-4.4%
0.01%
-16.7%
Q3 2017$21,029,000
-0.4%
400,774
-3.4%
0.01%0.0%
Q2 2017$21,124,000
+13.4%
414,675
-1.2%
0.01%
+20.0%
Q1 2017$18,632,000
+5.1%
419,536
+4.5%
0.01%0.0%
Q4 2016$17,726,000
+22.5%
401,293
+11.1%
0.01%
+25.0%
Q3 2016$14,470,000
-15.8%
361,223
+0.4%
0.00%
-20.0%
Q2 2016$17,177,000
+7.0%
359,872
-6.0%
0.01%0.0%
Q1 2016$16,054,000
-3.8%
382,773
+1.0%
0.01%0.0%
Q4 2015$16,689,000
-10.0%
378,884
-2.5%
0.01%
-16.7%
Q3 2015$18,544,000
-7.8%
388,402
+12.5%
0.01%0.0%
Q2 2015$20,110,000
+18.0%
345,111
+2.2%
0.01%
+50.0%
Q1 2015$17,043,000
-13.9%
337,543
-23.3%
0.00%
-20.0%
Q4 2014$19,787,000
+17.3%
440,090
-3.9%
0.01%0.0%
Q3 2014$16,871,000
-59.2%
457,917
-51.2%
0.01%
-16.7%
Q2 2014$41,386,000
+108.2%
937,456
+104.9%
0.01%
+20.0%
Q1 2014$19,876,000
+35.6%
457,418
+32.7%
0.01%
+25.0%
Q4 2013$14,655,000
-37.9%
344,824
-50.4%
0.00%0.0%
Q3 2013$23,592,000
+123.3%
694,676
+105.5%
0.00%
+33.3%
Q2 2013$10,563,000338,1220.00%
Other shareholders
CONMED CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Endurant Capital Management LP 41,984$4,234,0863.80%
Ranger Investment Management 334,874$33,772,0432.24%
SECTORAL ASSET MANAGEMENT INC 114,000$11,496,9002.24%
EARNEST PARTNERS LLC 2,265,092$228,434,5281.32%
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID 144,376$14,560,3201.01%
EPIQ PARTNERS, LLC 10,463$1,055,1940.80%
Hood River Capital Management LLC 236,127$23,813,4080.76%
Heritage Wealth Partners, LLC 3,375$340,3690.73%
Champlain Investment Partners, LLC 943,260$95,127,7710.62%
WESTWOOD HOLDINGS GROUP INC 559,157$56,3910.53%
View complete list of CONMED CORP shareholders